Your browser doesn't support javascript.
loading
Prolactin Induced Protein (PIP) is a potential biomarker for early stage and malignant breast cancer.
Gangadharan, Anju; Nyirenda, Themba; Patel, Kishan; Jaimes-Delgadillo, Nydia; Coletta, Dominique; Tanaka, Takemi; Walland, Ayal C; Jameel, Zena; Vedantam, Srinivasa; Tang, Sittinon; Mannion, Ciaran; Lee, Grace Y; Goy, Andre; Pecora, Andrew; Suh, K Stephen.
Afiliación
  • Gangadharan A; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Nyirenda T; Biostatistics, Department of Research, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Patel K; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Jaimes-Delgadillo N; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Coletta D; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Tanaka T; Stephenson Cancer Center, University of Oklahoma, Oklahoma City, OK 73104, USA.
  • Walland AC; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Jameel Z; Department of Pathology, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Vedantam S; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Tang S; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Mannion C; Department of Pathology, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Lee GY; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Goy A; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Pecora A; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA.
  • Suh KS; The Genomics and Biomarkers Program, The John Theurer Cancer Center, Hackensack University Medical Center, Hackensack Meridian Health, Hackensack, NJ 07601, USA. Electronic address: Kwangsun.Suh@HackensackMeridian.org.
Breast ; 39: 101-109, 2018 Jun.
Article en En | MEDLINE | ID: mdl-29656222
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Glicoproteínas / Proteínas Portadoras / Biomarcadores de Tumor Límite: Female / Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Glicoproteínas / Proteínas Portadoras / Biomarcadores de Tumor Límite: Female / Humans Idioma: En Revista: Breast Asunto de la revista: ENDOCRINOLOGIA / NEOPLASIAS Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos